Answers are grounded in this paper and cite their sources.
BACKGROUND: The inflammatory biomarker galectin-3 contributes to pathologic conditions such as heart failure and stimulates murine thrombogenesis. Its association with venous thromboembolism (VTE) has been sparsely studied. OBJECTIVES: rs4644 SNP with VTE incidence. METHODS: We measured plasma galectin-3 in 9,916 participants in the Atherosclerosis Risk in Communities (ARIC) study cohort in 1996 - 1998 and identified VTEs through 2013. Using Cox regression, we estimated the hazard ratio associating galectin-3 with incident VTE over a median of 13.9 years. Replication was sought in the Cardiovascular Health Study (CHS). RESULTS: gene was associated with higher galectin-3 level, and in whites, with an increased rate of VTE. CONCLUSION: Galectin-3 levels were associated positively with VTE incidence.
No takes yet. Share an insight, caveat, or question.
Fashanu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: